Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Microbiology (Seoul, Korea)|February 4, 2010
Hepatitis B virus core interacts with the host cell nucleolar protein, nucleophosmin 1Su Jin Lee, Hee Youn Shim, Antony Hsieh, et al.
Science Advances|December 5, 2020
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitorsAntony Hsieh, Jason R Pitarresi, Jonathan Lerner, et al.
Calcified Tissue International|December 25, 2012
1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6Rimpi K Saini, Ichiro Kaneko, Peter W Jurutka, et al.
Cell Reports. Medicine|July 18, 2020
DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation BurdenDavid Hsiehchen, Antony Hsieh, Robert M Samstein, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|July 13, 2013
Tandem duplication PCR: an ultrasensitive assay for the detection of internal tandem duplications of the FLT3 geneMing-Tseh Lin, Li-Hui Tseng, Katie Beierl, et al.
Hepatology (Baltimore, Md.)|January 30, 2018
Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in miceXiaoying Liu, Grace L Guo, Bo Kong, et al.
Nature Cell Biology|August 6, 2021
Diverse heterochromatin-associated proteins repress distinct classes of genes and repetitive elementsRyan L McCarthy, Kelsey E Kaeding, Samuel H Keller, et al.
Cancer Discovery|February 16, 2021
PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic VulnerabilityJason R Pitarresi, Robert J Norgard, Anna M Chiarella, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 2